MarketInOut Stock Screener Log In | Sign Up
 

Jade Biosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/21/2026 09:34
Jade Biosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization856.66 mln
Float54.50 mln
Earnings Date11/16/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

91 / 100
Top performer

Debt / Equity

0.00
Debt-free

ROE

-52.85
Deeply negative

ROA

-48.87
Deeply negative

Business Description

Jade Biosciences is a Waltham, Massachusetts company focused on creating new treatments for people suffering from autoimmune conditions. Its most advanced program, JADE101, is currently being tested in humans and works by targeting a specific protein involved in driving harmful immune responses. The company has two earlier-stage programs in the pipeline and works alongside Paragon Therapeutics to advance its research.

Key Fundamentals

EPS-1.92
ROE-52.85
ROIC-1,568
ROA-48.87
EBITDA, mln-153
EV / EBITDA-2.50
EV / EBIT-2.50

Quote Details

Last 14.84
Change -0.02 (-0.13%)
Open 14.84
Volume 6,409
Turnover 95,110
Average Volume 924,542

Financial Ratios

Leverage Ratio1.07
Current Ratio14.93
Price / Book2.04
Price / Tangible Book2.04
Debt / Equity0.00

Financial Strength

Piotroski F-Score 4 / 9
Short Ratio12.01
Short % of Float23.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.42% 94 / 100   
1 Month -11.46% 32 / 100   
2 Months -27.54% 20 / 100   
6 Months -41.53% 18 / 100   
1 Year 48.4% 93 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog